Independent report: Commercial clinical trials in the UK: the Lord O’Shaughnessy review

Independent report: Commercial clinical trials in the UK: the Lord O’Shaughnessy review In February 2023, the government commissioned an independent review to offer recommendations on how to resolve key challenges in conducting commercial clinical trials in the UK and transform the UK commercial clinical trial environment. The review sets out 27 recommendations, including both priority actions to progress in 2023 and longer-term ambitions for UK commercial clinical trials. Department of Health and Social Care